7336-80-3

Basic information

• Product Name: inositol 2-monophosphate
• Synonyms: inositol 2-monophosphate;1D-myo-inositol 2-phosphate
• CAS NO: 7336-80-3
• Molecular Formula: C₆H₁₃O₉P
• Molecular Weight: 260.1358
• Mol File: 7336-80-3.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 517.4°Cat760mmHg
• Flash Point: 266.7°C
• Appearance: /
• Density: 2.02g/cm³
• Vapor Pressure: 7.17E-13mmHg at 25°C
• Refractive Index: 1.65
• CAS DataBase Reference: inositol 2-monophosphate(CAS DataBase Reference)
• NIST Chemistry Reference: inositol 2-monophosphate(7336-80-3)
• EPA Substance Registry System: inositol 2-monophosphate(7336-80-3)

Safety Data

• Hazardous Substances Data: 7336-80-3(Hazardous Substances Data)

Usage

Description

Inositol 2-monophosphate is a myo-inositol monophosphate in which the phosphate group is located at the 2-position. It is an important molecule involved in various cellular processes and signaling pathways.

Uses

Used in Pharmaceutical Industry:
Inositol 2-monophosphate is used as a pharmaceutical compound for its potential therapeutic applications. It plays a crucial role in cellular signaling and has been implicated in the regulation of various physiological processes, making it a promising target for drug development.
Used in Research Applications:
Inositol 2-monophosphate is used as a research tool for studying the role of inositol phosphates in cellular processes. It can be used to investigate the mechanisms of inositol phosphate signaling and its involvement in various biological pathways.
Used in Diagnostic Applications:
Inositol 2-monophosphate can be used as a biomarker for certain diseases or conditions. Its levels can be measured to assess the status of inositol phosphate metabolism and provide insights into the underlying pathophysiology of the disease.
Used in Food Industry:
Inositol 2-monophosphate may have potential applications in the food industry as a functional ingredient. It could be used to enhance the nutritional value of food products or to develop novel food formulations with specific health benefits.

InChI:InChI=1/C6H13O9P/c7-1-2(8)4(10)6(5(11)3(1)9)15-16(12,13)14/h1-11H,(H2,12,13,14)/t1?,2-,3+,4+,5-,6?

Upstream product

• 26277-06-5 (+/-)-2,3,4,5,6-penta-O-benzyl-myo-inositol 1-(dihydrogen phosphate) 
• 98510-20-4 myo-Inositol orthoformate 
• 114828-07-8 myo-inositol 1,3,5-monoorthoformate 4,6-phosphate dibenzyl ester 
• 87-89-8 D-myo-inositol 
• 75194-94-4 3,3,7,7-tetramethyl-2,8-dioxa-5-aza-1λ³-phosphabicyclo(3,3,0)octane 
• 50730-11-5 2-O-diphenoxyphosphinoyl-1,3,4,5,6-penta-O-acetyl-myo-inositol 
• 52389-41-0 1(3),3(1),4(6),5,6(4)-penta-O-acetyl-sn-myoinositol 
• 98510-25-9 meso-4,6-di-O-benzyl-D-myo-inositol-1,3,5-O-orthoformate 
• 120268-33-9 4/6-O-benzyl-myo-inositol 1,3,5-monoorthoformate 
• 864372-83-8 2,4,5-tri-O-acetyl-3,6-di-O-benzyl-D-myo-inositol 
• 864372-88-3 1,4,5-tri-O-acetyl-3,6-di-O-benzyl-D-myo-inositol 
• 864372-76-9 4,5-di-O-acetyl-3,6-di-O-benzyl-D-myo-inositol 
• 864372-74-7 (1S,2R,3R,4S)-2,3-di-O-acetyl-1,4-di-O-benzylconduritol B 
• 864372-89-4 1,4,5-tri-O-acetyl-3,6-di-O-benzyl-2-O-(3-oxo-1,5-dihydro-3λ⁵-2,4,3-benzodioxaphosphepin-3-yl)-D-myo-inositol 

Downstream Products

• 551-72-4 inositol 
• 86119-84-8 phosphoric acid 
• 33608-52-5 DL-O¹,O²-hydroxyphosphoryl-myo-inositol 

Relevant articles and documents

Flexible stereo- and regioselective synthesis of myo-inositol phosphates (part 1): Via symmetrical conduritol B derivatives

A practical route is described for the preparation of myo-inositol polyphosphates. Optically pure myo-inositol derivatives can be prepared from p-benzoquinone in both forms by enzymatic resolution of a C2- symmetric diacetoxyconduritol B key in

The pathway of dephosphorylation of myo-inositol hexakisphosphate by phytases from wheat bran of Triticum aestivum L. cv. Nourin #61

Phytases are the primary enzymes responsible for the hydrolysis of phytic acid, myo-inositol-1, 2, 3, 4, 5, 6-hexakisphosphate (InsP6). The pathway of hydrolysis of InsP6 by phytase from wheat bran of Triticum aestivum L. cv. Nourin #61 is proved in this study. Structures of the intermediates were established by a variety of nuclear magnetic resonance techniques (1H-, two-dimensional 1H-1H coupling-correlation spectra and two-dimensional 31P-1H correlation spectra), gas chromatography, and bioassay. On the basis of the structures identified, initial hydrolysis of the phosphate ester occurs at the D/L-4 position of InsP6 to yield D/L-Ins (1, 2, 3, 5, 6) P5. After the dephosphorylation, the pathway of dephosphorylation is divided into two routes. The main route proceeds via D/L-Ins (1, 2, 5, 6) P4, D/L-Ins (1, 2, 6) P3 and D/L-Ins (1, 2) P2, while the minor route proceeds via D/L-Ins (1, 2, 3, 6) P4, Ins (1, 2, 3) P3 and D/L-Ins (1, 2) P2. D/L-Ins (1, 2) P2 is hydrolyzed at the D/L-1 or 2-position, and finally myo-inositol is produced.

Derivatives of cyclohexane

New derivatives of cyclohexane in substantially pure form suitable as a pharmaceutical, foodstuff or as a stabilizer.